148 related articles for article (PubMed ID: 15932828)
1. First-trimester ductus venosus, nasal bones, and Down syndrome in a high-risk population.
Prefumo F; Sethna F; Sairam S; Bhide A; Thilaganathan B
Obstet Gynecol; 2005 Jun; 105(6):1348-54. PubMed ID: 15932828
[TBL] [Abstract][Full Text] [Related]
2. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester.
Geipel A; Willruth A; Vieten J; Gembruch U; Berg C
Ultrasound Obstet Gynecol; 2010 May; 35(5):535-9. PubMed ID: 20183867
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the ductus venosus, tricuspid blood flow and the nasal bone in second-trimester screening for trisomy 21.
Stressig R; Kozlowski P; Froehlich S; Siegmann HJ; Hammer R; Blumenstock G; Kagan KO
Ultrasound Obstet Gynecol; 2011 Apr; 37(4):444-9. PubMed ID: 20645398
[TBL] [Abstract][Full Text] [Related]
4. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
5. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
Sepulveda W; Wong AE; Dezerega V
Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
[TBL] [Abstract][Full Text] [Related]
6. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
7. First-trimester screening for chromosomal abnormalities.
Nicolaides KH
Semin Perinatol; 2005 Aug; 29(4):190-4. PubMed ID: 16104667
[TBL] [Abstract][Full Text] [Related]
8. Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy.
Borrell A; Martinez JM; Serés A; Borobio V; Cararach V; Fortuny A
Prenat Diagn; 2003 Nov; 23(11):921-6. PubMed ID: 14634979
[TBL] [Abstract][Full Text] [Related]
9. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus.
Mavrides E; Sairam S; Hollis B; Thilaganathan B
BJOG; 2002 Sep; 109(9):1015-9. PubMed ID: 12269675
[TBL] [Abstract][Full Text] [Related]
10. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
Maiz N; Valencia C; Emmanuel EE; Staboulidou I; Nicolaides KH
Obstet Gynecol; 2008 Sep; 112(3):598-605. PubMed ID: 18757658
[TBL] [Abstract][Full Text] [Related]
11. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
Maiz N; Plasencia W; Dagklis T; Faros E; Nicolaides K
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):256-60. PubMed ID: 18307193
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three-dimensional ultrasound.
Peralta CF; Falcon O; Wegrzyn P; Faro C; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 May; 25(5):464-7. PubMed ID: 15816008
[TBL] [Abstract][Full Text] [Related]
13. First trimester ultrasound screening for Down syndrome based on maternal age, fetal nuchal translucency and different combinations of the additional markers nasal bone, tricuspid and ductus venosus flow.
Abele H; Wagner P; Sonek J; Hoopmann M; Brucker S; Artunc-Ulkumen B; Kagan KO
Prenat Diagn; 2015 Dec; 35(12):1182-6. PubMed ID: 26223508
[TBL] [Abstract][Full Text] [Related]
14. Fronto-nasal dysplasia and atrio-ventricular canal in a fetus with trisomy 18 identified by absent nasal bones during first trimester screening scan.
Tonni G; De Felice C; Asioli S; Ventura A
Congenit Anom (Kyoto); 2007 Mar; 47(1):45-8. PubMed ID: 17300689
[TBL] [Abstract][Full Text] [Related]
15. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
[TBL] [Abstract][Full Text] [Related]
16. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
[TBL] [Abstract][Full Text] [Related]
17. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
Bronshtein M; Zimmer EZ; Blazer S
Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
[TBL] [Abstract][Full Text] [Related]
18. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
[TBL] [Abstract][Full Text] [Related]
19. Absence of an anatomical origin for altered ductus venosus flow velocity waveforms in first-trimester human fetuses with increased nuchal translucency.
Burger NB; Matias A; Kok E; de Groot CJ; Christoffels VM; Bekker MN; Haak MC
Prenat Diagn; 2016 Jun; 36(6):537-44. PubMed ID: 27060369
[TBL] [Abstract][Full Text] [Related]
20. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
